1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 27 APRIL 2015

Key Pharma News 27 APRIL 2015

  • April 2015
  • -
  • Espicom Business Intelligence
  • -
  • 41 pages

Industry Trend Analysis - Teva's Proposed Acquisition Of Mylan Will Reshape The Generic Industry
Industry Trend Analysis - Lilly And Merck Will Benefit From BMS Erbitux Exit
Industry Trend Analysis - Argos/Lummy Deal Indicative Of Shift Towards Innovation Within Sino-foreign Partnerships
Industry Trend Analysis - Immuno-Oncology Market Will Become Crowded As Focus Increases
Industry Trend Analysis - Further HBV Deals Will Follow Ichor/Janssen's Agreement
Industry Trend Analysis - Roche's Pipeline Will Benefit From Genomic Diagnostic Acquisition
Industry Trend Analysis - J&J's Neuroscience Pipeline Will Need Investment
Industry Brief - Valeant Completes Salix Acquisition
Industry Brief - Eisai Realigns US Operations
Industry Brief - AOP Orphan/Rigi Healthcare Create Rigi Orphan USA To Focus On Rare Diseases
Industry Trend Analysis - J&J Oncology Segment Gaining Momentum
Industry Trend Analysis - Successful Acquisition Of Perrigo Will Boost Mylan's Global Reach And Portfolio
Industry Brief - AbbVie Extends Exchange Offer To Acquire Pharmacyclics
Industry Trend Analysis - First Generic Copaxone Approved But Launch Remains Uncertain
Industry Trend Analysis - AbbVie Set To Face Further HCV Drug Price Battles In Japan
Industry Trend Analysis - Cost Of Cancer Treatment Will Continue To Rise
Industry Brief - FDA Grants Priority Review To AbbVie's All-Oral IFN-Free HCV GT4 Therapy
Industry Brief - Ono Seeks Japanese Approval For Additional Indication Of Opdivo
Industry Trend Analysis - Drug Delivery Experience Needed To Improve GSK's Vaccines Business
Industry Trend Analysis - Keytruda's Impending Approval Will Cause BMS' NSCLC Advantage To Slip
Industry Brief - FDA Accepts NDA Filing For Bendamustine Rapid Infusion
Industry Brief - ViiV's Triumeq Launched In Japan For HIV
Industry Brief - Japan Vaccine Seeks Japanese Approval For Intradermal Flu Vaccine
Industry Trend Analysis - Afrezza Aggressive Pricing Strategy View Playing Out
Industry Brief - Zykadia Approved In Canada For Select Treatment-Resistant LC
Industry Brief - Mylan Settles Sildenafil Citrate Patent Litigation In US
Industry Brief - FDA Approves Corlanor For Chronic HF
Industry Trend Analysis - Patent Challenge Exposes Qsymia's Weaknesses
Industry Brief - FDA Accepts Adcetris sBLA; Grants Priority Review For HL Following ASCT
Industry Brief - Oasmia's Paclical Approved In Russia
Industry Brief - Saxenda Available In US
Industry Trend Analysis - Sovaldi Pricing To Remain An Issue Despite Groundbreaking Programme
Industry Brief - GSK's Malaria Vaccine Candidate Demonstrates Prolonged Efficacy In Phase III Trial
Industry Trend Analysis - Pfizer Cannot Rely Solely On Resurrecting Shelved Oncology Candidates To Drive Growth
Industry Brief - Xalkori Gains FDA Breakthrough Therapy Designation For ROS1-Positive NSCLC
Industry Brief - Merck KGaA/Pfizer Initiate Avelumab Phase III Study In Stage IIIb/IV NSCLC
Industry Trend Analysis - GW Remains A Risky Investment; Results In H215 Will Be Key
Industry Brief - Active Biotech/Ipsen Discontinue Tasquinimod Development In PCA
Industry Trend Analysis - Positive Ibrance Data Set Pfizer Further Ahead Although Competition Will Arrive Soon
Industry Trend Analysis - Expansion Of Copanlisib Programme Highlights Changes Within Bayer And The NHL Market
Industry Brief - Portola's Andexanet Alfa Achieves Primary Endpoint For Prolonged Reversal Of Eliquis
Industry Brief - Eisai/Arena Complete Registrational Trials Of Lorcaserin ER Formulation
Industry Brief - Opdivo Phase III LC Trial Stopped Early Following Favourable OS Results
Industry Trend Analysis - Genomic Profiling Expanding Utility Of Targeted Drugs
Industry Trend Analysis - AstraZeneca Will Continue To Increase Oncology Segment's Strength
Industry Trend Analysis - Ixekizumab Trials Are Progressing Well But A Competitive Market Looms

Table Of Contents

Key Pharma News 27 APRIL 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.